UPDATES FROM SAC & SUBCOMMITTEES We are very pleased to have many of our subcommittee Deputy Chairs contributing reports this year in UPdate. Along with the subcommittee Chairs, the Deputy Chairs play a very important role in supporting the functions and outputs of the subcommittees and we thank them for their ongoing contributions.
Scientific Advisory Committee (SAC) The ANZUP Scientific Advisory Committee comprises representatives from a broad range of disciplines. This ensures that we have many minds from many backgrounds and perspectives constantly scanning the horizon for evidence and recognising areas of clinical need. The SAC sets ANZUP’s scientific strategic direction and oversees the work we do to achieve our goals. It prioritises based on our strategic plan and also acts as a strong resource for those preparing concepts or more mature documents. The SAC meets quarterly by teleconference. We hold an open face to face meeting at the ASM every year and all ANZUP members are invited and welcome to attend. We
held another face to face planning meeting in November to discuss strategic planning and how best to implement or improve processes. This was highly productive and will give us a useful structure for future work. I am delighted to announce that Professor Bertrand Tombal, current chairman of the Clinical Trial Division of the European Organization for Research and Treatment of Cancer (EORTC), will be joining the SAC as one of our international members. The SAC also farewells Dr Martin Gleave – we sincerely thank him for his contribution to the committee. On that note, thank you to all the members of the SAC for the generous donation of your time and expertise. IAN DAVIS Chair, ANZUP Scientific Advisory Committee
2017 ANZUP GU Preceptorship in Prostate Cancer 3-4 November 2017, Novotel Glen Waverley, Melbourne This 1 ½ day workshop will cover landmark clinical trials in prostate cancer. Our target participants are trainees and junior specialists (first 5 years of practice) in urology, radiation oncology, medical oncology and imaging. Successful applicants will be supported to attend this exciting new initiative. Areas to be covered include screening, multimodality management of early, locally advanced and metastatic disease and supportive care. Further information will be provided soon.
12 | ANZUP UPdate
